Packaging Machinery Manufacturers Institute Pharmaceutical and Nutraceutical Market Research
Executive Highlights 1.
Pharmaceutical manufacturing move to offshore production is greatly tempered by the need for full FDA compliance and the threat of counterfeiting drugs so much of the production will remain in the U.S. (Summary pg 5, Appendix Details pgs 14-15)
2. The role of contract manufacturing continues to increase. The most important
advantages are real cost savings from reducing capital expenditures, flexible line changes, smaller batch runs, supplementing equipment that manufacturers don’t have in-house, significant reduction in the number of lines dedicated to one product and getting a product to market more quickly. (Summary pg 7, Appendix Details pgs 24-25)
3. The move to blister packaging and away from bottles will continue to grow for
(Summary pg 7, Appendix Details pgs 21-22)
greater convenience with tablets and capsules. There is a major push for products to enhance user convenience which will drive new and unique delivery systems.
4. The top challenges that packaging machine builders will need to address in the
future to satisfy the demand for validation compliance are; product traceability, online diagnostic software, vision inspection systems integrated on their machines, and the ability to receive control system upgrades from remote locations.
(Summary pg 11, Appendix Details pgs 34-36)
5. Sustainable packaging requirements continue increase and challenge package
designers to going green, adhering to the demand for more recycling and reducing the weight and volume of the entire package. (Summary pg 10, Appendix Details pg 31)
6. Anti-counterfeiting requirements will continue to grow in importance with a definite
trend toward RFID and slight increases in the use of holograms, color-shifting and covert markings. A decrease in bar-code checks and non-contact inspection technology is predicted as RFID gains a strong foot-hold in their operations.
(Summary pg 8, Appendix Details pgs 26-27)
1